CHRONIC SPONTANEOUS URTICARIA

This study looks at the long-term safety and effectiveness of barzolvolimab for adults with chronic spontaneous urticaria (CSU), a condition causing frequent hives and itching. Participants have already completed earlier phase 3 trials and will continue receiving the drug to see …

This study tests a new drug called remibrutinib in teens aged 12 to 17 who have chronic hives that don't get better with standard allergy pills. The goal is to see if the drug reduces itching and hives better than a placebo. Participants will take the drug or placebo for 24 weeks…

This study follows about 3,280 adults with chronic spontaneous urticaria (CSU) to see how well remibrutinib controls their hives in real-world settings. Participants either continue standard antihistamines or switch to remibrutinib, as decided by their doctor. The main goal is to…

This study follows 505 adults with chronic spontaneous urticaria (CSU) to see how well remibrutinib controls hives in everyday medical practice. Participants either continue standard antihistamines or switch to remibrutinib. The goal is to measure symptom control and safety over …

This program gives adults with chronic spontaneous urticaria (long-term hives) access to an experimental drug called remibrutinib. It is for people whose hives did not improve with standard treatments. The goal is to control symptoms, not cure the condition.

This study looks at whether people with chronic spontaneous urticaria (long-lasting hives) who are doing well on omalizumab shots every 4 weeks can safely stretch the time between shots and still keep their hives under control. About 40 adults will take part. If successful, it co…

This study looks at how well the drug remibrutinib works for people with chronic spontaneous urticaria (long-term hives with no clear cause). Researchers will survey 350 patients in the U.S. to see if the drug improves symptom control and quality of life. The goal is to understan…

This study tests a daily oral medication called ritlecitinib for adults with chronic spontaneous urticaria (CSU) — a condition causing itchy hives and deep skin swelling without a clear trigger. About 200 participants who haven't found relief from antihistamines will be randomly …

This study tests an experimental drug called BLU-808 for people with chronic hives (either triggered by heat, cold, or pressure, or happening for no clear reason) that don't get better with standard allergy pills. The goal is to see if the drug is safe and can reduce hives sympto…

This study follows 400 people with chronic spontaneous urticaria (long-lasting hives) who are already prescribed dupilumab by their doctor. Researchers will collect information from medical records and patient surveys over 24 months to see how well the drug works in real life, it…

This early-stage trial tests the safety and tolerability of a new drug called HRS-3095 in 66 healthy adults aged 18-55. Researchers will also study how the drug moves through the body and how food affects it. The goal is to gather essential safety data before testing the drug in …

This early-stage study tests an experimental pill called EDP-978 in healthy adults to see if it is safe and how the body handles it. The drug is being developed for people with long-lasting hives. About 98 participants will receive either the drug or a placebo, and researchers wi…